Remove Acquisitions Remove Corporation Remove Pharmaceutical
article thumbnail

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Enter into a Letter of Intent for a Proposed Business Combination

Global Newswire by Notified: M&A

July 02, 2024 (GLOBE NEWSWIRE) -- Semnur Pharmaceuticals, Inc. a Cayman Islands corporation and special purpose acquisition company (Nasdaq: DECA, “SPAC”), today announced the signing of a letter of intent for a proposed business combination, which provides for a pre-transaction equity value of Semnur up to $2.0

article thumbnail

Boston Scientific to Acquire Axonics for $3.7 Billion

JD Supra: Mergers

Boston Scientific Corporation (“Boston Scientific”) announced on January 8 that it has entered into a definitive agreement to acquire Axonics, Inc. Morgan Healthcare Conference in San Francisco, which also saw the announcement of major acquisitions by large players in the pharmaceutical space. By: Knobbe Martens

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Monster Beverage Completes Acquisition of Bang Energy

Global Newswire by Notified: M&A

July 31, 2023 (GLOBE NEWSWIRE) -- Monster Beverage Corporation (NASDAQ: MNST) today announced that its subsidiary, Blast Asset Acquisition LLC, completed its acquisition of substantially all of the assets of Vital Pharmaceuticals, Inc. CORONA, Calif.,

article thumbnail

From Mergers to Acquisitions: How to Successfully Execute a Corporate Restructuring Plan

Devensoft

Corporate restructuring can be a game-changer for any organization, whether it’s a merger, acquisition, or any other strategic move. We, at Devensoft, help companies with their end-to-end M&A and have worked with several clients in the corporate sector to navigate this complex process.

article thumbnail

Virbac to take a leading position in Japan through the acquisition of Sasaeah

Global Newswire by Notified: M&A

Formed through the combination of two legacy animal health providers (Fujita Pharmaceutical Co. under the stewardship of ORIX Corporation, Sasaeah generates annual revenues of about €75 million, of which 50% from vaccines. and Kyoto Biken Laboratories Inc.)

article thumbnail

Shareholders vs. Stakeholders - Understanding Corporate Responsibilities

Peak Frameworks

In the world of finance and corporate responsibility, two terms frequently arise: "stakeholder" and "shareholder." A shareholder is an individual or entity that owns shares or stock in a corporation. What is a Shareholder? By virtue of their ownership, they possess a direct financial interest in the company's success.

article thumbnail

Sosei Heptares - Investor and Press Conference on Today’s Announcement Regarding the Acquisition and License Transaction with Idorsia

Global Newswire by Notified: M&A

Tokyo, Japan and Cambridge , UK, 20 July 2023 – Sosei Group Corporation (“the Company”; TSE: 4565), will hold an investor and press conference on today’s announcement; “Sosei Heptares Acquires Idorsia’s Pharmaceuticals Business in Japan and APAC (ex-China), Accelerating its Transformation into a Fully Integrated Biopharmaceutical Company.”